The startling properties of fibroblast growth factor 2: How to exit mammalian cells without a signal peptide at hand

Journal of Biological Chemistry

Volumn 290, Issue 45, 2015, Pages 27015-27020

  La Venuta, Giuseppe ^a   Zeitler, Marcel ^a   Steringer, Julia P ^a   Müller, Hans Michael ^a   Nickel, Walter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOLOGICAL MEMBRANES; BODY FLUIDS; CELL CULTURE; CELL MEMBRANES; DIAGNOSIS; ENZYMES; FIBROBLASTS; GLYCOPROTEINS; MACHINERY; MAMMALS; OLIGOMERIZATION; OLIGOMERS; PEPTIDES; PHYSIOLOGY; PORE SIZE; PROTEINS;

ENDOPLASMIC RETICULUM; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE PROTEOGLYCANS; INTEGRAL MEMBRANE PROTEINS; PHOSPHATIDYLINOSITOL; PROTEIN TRANSLOCATION; TUMOR-INDUCED ANGIOGENESIS; TYROSINE PHOSPHORYLATION;

ENZYME ACTIVITY;

ATP1A1 PROTEIN; FIBROBLAST GROWTH FACTOR 2; MEMBRANE PROTEIN; PHOSPHOINOSITIDE PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PROTEIN; PROTEOHEPARAN SULFATE; TEC KINASE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); HEPARAN SULFATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; TEC PROTEIN-TYROSINE KINASE;

CELL SURFACE; CHANNEL GATING; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMISTRY; GENETICS; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; RNA INTERFERENCE;

ANIMALS; CELL MEMBRANE; ENDOPLASMIC RETICULUM; FIBROBLAST GROWTH FACTOR 2; GOLGI APPARATUS; HEPARITIN SULFATE; HUMANS; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PROTEIN MULTIMERIZATION; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84946615264     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R115.689257     Document Type: Review

References (58)

1. Rapoport, T. A. (2007) Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature 450, 663-669.
2. Rothman, J. E. (1994) Mechanisms of intracellular protein transport. Nature 372, 55-63.
3. Rothman, J. E., and Wieland, F. T. (1996) Protein sorting by transport vesicles. Science 272, 227-234.
4. Malhotra, V. (2013) Unconventional protein secretion: An evolving mechanism. EMBO J. 32, 1660-1664.
5. Nickel, W., and Rabouille, C. (2009) Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148-155.
6. Nickel, W., and Seedorf, M. (2008) Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu. Rev. Cell Dev. Biol. 24, 287-308.
7. Piccioli, P., and Rubartelli, A. (2013) The secretion of IL-1β and options for release. Semin. Immunol. 25, 425-429.
8. Rabouille, C., Malhotra, V., and Nickel, W. (2012) Diversity in unconventional protein secretion. J. Cell Sci. 125, 5251-5255.
9. Zhang, M., and Schekman, R. (2013) Cell biology: unconventional secretion, unconventional solutions. Science 340, 559-561.
10. Nickel, W. (2010) Pathways of unconventional protein secretion. Curr. Opin. Biotechnol. 21, 621-626.
11. Steringer, J. P., Müller, H. M., and Nickel, W. (2015) Unconventional secretion of fibroblast growth factor 2: A novel type of protein translocation across membranes? J. Mol. Biol. 427, 1202-1210.
12. Wegehingel, S., Zehe, C., and Nickel, W. (2008) Rerouting of fibroblast growth factor 2 to the classical secretory pathway results in post-translational modifications that block binding to heparan sulfate proteoglycans. FEBS Lett. 582, 2387-2392.
13. Nickel, W. (2011) The unconventional secretory machinery of fibroblast growth factor 2. Traffic 12, 799-805.
14. Schäfer, T., Zentgraf, H., Zehe, C., Brügger, B., Bernhagen, J., and Nickel, W. (2004) Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J. Biol. Chem. 279, 6244-6251.
15. Neupert, W., and Herrmann, J. M. (2007) Translocation of proteins into mitochondria. Annu. Rev. Biochem. 76, 723-749.
16. Osborne, A. R., Rapoport, T. A., and van den Berg, B. (2005) Protein translocation by the Sec61/SecY channel. Annu. Rev. Cell Dev. Biol. 21, 529-550.
17. Steringer, J. P., Bleicken, S., Andreas, H., Zacherl, S., Laussmann, M., Temmerman, K., Contreras, F. X., Bharat, T. A., Lechner, J., Müller, H. M., Briggs, J. A., García-Sáez, A. J., and Nickel, W. (2012) Phosphatidylinositol 4, 5-bisphosphate (PI(4, 5)P2)-dependent oligomerization of fibroblast growth factor 2 (FGF2) triggers the formation of a lipidic membrane pore implicated in unconventional secretion. J. Biol. Chem. 287, 27659-27669.
18. Temmerman, K., Ebert, A. D., Müller, H. M., Sinning, I., Tews, I., and Nickel, W. (2008) A direct role for phosphatidylinositol-4, 5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 9, 1204-1217.
19. Temmerman, K., and Nickel, W. (2009) A novel flow cytometric assay to quantify interactions between proteins and membrane lipids. J. Lipid Res. 50, 1245-1254.
20. Müller, H. M., Steringer, J. P., Wegehingel, S., Bleicken, S., Münster, M., Dimou, E., Unger, S., Weidmann, G., Andreas, H., García-Sáez, A. J., Wild, K., Sinning, I., and Nickel, W. (2015) Formation of disulfide bridges drives oligomerization, membrane pore formation and translocation of fibroblast growth factor 2 to cell surfaces. J. Biol. Chem. 290, 8925-8937.
21. Zeitler, M., Steringer, J. P., Müller, H. M., Mayer, M. P., and Nickel, W. (2015) HIV-Tat forms phosphoinositide-dependent membrane pores implicated in unconventional protein secretion. J. Biol. Chem. 290, 21976-21984.
22. Nickel, W. (2007) Unconventional secretion: An extracellular trap for export of fibroblast growth factor 2. J. Cell Sci. 120, 2295-2299.
23. Engling, A., Backhaus, R., Stegmayer, C., Zehe, C., Seelenmeyer, C., Kehlenbach, A., Schwappach, B., Wegehingel, S., and Nickel, W. (2002) Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells. J. Cell Sci. 115, 3619-3631.
24. Trudel, C., Faure-Desire, V., Florkiewicz, R. Z., and Baird, A. (2000) Translocation of FGF2 to the cell surface without release into conditioned media. J. Cell Physiol. 185, 260-268.
25. Zehe, C., Engling, A., Wegehingel, S., Schäfer, T., and Nickel, W. (2006) Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2. Proc. Natl. Acad. Sci. U.S.A. 103, 15479-15484.
26. Nugent, M. A., and Iozzo, R. V. (2000) Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32, 115-120.
27. Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R., and Rusnati, M. (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16, 159-178.
28. Ribatti, D., Vacca, A., Rusnati, M., and Presta, M. (2007) The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev. 18, 327-334.
29. Backhaus, R., Zehe, C., Wegehingel, S., Kehlenbach, A., Schwappach, B., and Nickel, W. (2004) Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding. J. Cell Sci. 117, 1727-1736.
30. Torrado, L. C., Temmerman, K., Müller, H. M., Mayer, M. P., Seelenmeyer, C., Backhaus, R., and Nickel, W. (2009) An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation. J. Cell Sci. 122, 3322-3329.
31. Yang, W. C., Collette, Y., Nunès, J. A., and Olive, D. (2000) Tec kinases: A family with multiple roles in immunity. Immunity 12, 373-382.
32. Ebert, A. D., Laussmann, M., Wegehingel, S., Kaderali, L., Erfle, H., Reichert, J., Lechner, J., Beer, H. D., Pepperkok, R., and Nickel, W. (2010) Teckinase- mediated phosphorylation of fibroblast growth factor 2 is essential for unconventional secretion. Traffic 11, 813-826.
33. Bradshaw, J. M. (2010) The Src, Syk, and Tec family kinases: distinct types of molecular switches. Cell. Signal. 22, 1175-1184.
34. Lewis, C. M., Broussard, C., Czar, M. J., and Schwartzberg, P. L. (2001) Tec kinases: modulators of lymphocyte signaling and development. Curr. Opin. Immunol. 13, 317-325.
35. Liu, P., Cheng, H., Roberts, T. M., and Zhao, J. J. (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8, 627-644.
36. Zacherl, S., La Venuta, G., Müller, H. M., Wegehingel, S., Dimou, E., Sehr, P., Lewis, J. D., Erfle, H., Pepperkok, R., and Nickel, W. (2015) A direct role for ATP1A1 in unconventional secretion of fibroblast growth factor 2. J. Biol. Chem. 290, 3654-3665.
37. Kaplan, J. H. (2002) Biochemistry of Na, K-ATPase. Annu. Rev. Biochem. 71, 511-535.
38. +-ATPase in the plasma membrane of HeLa cells. J. Cell Sci. 121, 2159-2168.
39. Dahl, J. P., Binda, A., Canfield, V. A., and Levenson, R. (2000) Participation of Na, K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na, K-ATPase α subunits. Biochemistry 39, 14877-14883.
40. +-ATPase. J. Biol. Chem. 273, 544-551.
41. Debaisieux, S., Rayne, F., Yezid, H., and Beaumelle, B. (2012) The ins and outs of HIV-1 Tat. Traffic 13, 355-363.
42. Campbell, G. R., and Loret, E. P. (2009) What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology 6, 50.
43. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., and Rosen, C. A. (1989) Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol. 63, 1-8.
44. Chang, H. C., Samaniego, F., Nair, B. C., Buonaguro, L., and Ensoli, B. (1997) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. Aids 11, 1421-1431.
45. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
46. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261.
47. Shi, B., Raina, J., Lorenzo, A., Busciglio, J., and Gabuzda, D. (1998) Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4, 281-290.
48. Xiao, H., Neuveut, C., Tiffany, H. L., Benkirane, M., Rich, E. A., Murphy, P. M., and Jeang, K. T. (2000) Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. U.S.A. 97, 11466-11471.
49. Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., and Wong-Staal, F. (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84-86.
50. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P., and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287.
51. Rubartelli, A., Poggi, A., Sitia, R., and Zocchi, M. R. (1998) HIV-I Tat: A polypeptide for all seasons. Immunol. Today 19, 543-545.
52. + T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study. Retrovirology 11, 49.
53. Ensoli, B., Fiorelli, V., Ensoli, F., Cafaro, A., Titti, F., Buttò, S., Monini, P., Magnani, M., Caputo, A., and Garaci, E. (2006) Candidate HIV-1 Tat vaccine development: From basic science to clinical trials. AIDS 20, 2245-2261.
54. Ensoli, F., Cafaro, A., Casabianca, A., Tripiciano, A., Bellino, S., Longo, O., Francavilla, V., Picconi, O., Sgadari, C., Moretti, S., Cossut, M. R., Arancio, A., Orlandi, C., Sernicola, L., Maggiorella, M. T., Paniccia, G., Mussini, C., Lazzarin, A., Sighinolfi, L., Palamara, G., Gori, A., Angarano, G., Di Pietro, M., Galli, M., Mercurio, V. S., Castelli, F., Di Perri, G., Monini, P., Magnani, M., Garaci, E., and Ensoli, B. (2015) HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial. Retrovirology 12, 33.
55. Rayne, F., Debaisieux, S., Bonhoure, A., and Beaumelle, B. (2010) HIV-1 Tat is unconventionally secreted through the plasma membrane. Cell Biol. Int. 34, 409-413.
56. Rayne, F., Debaisieux, S., Yezid, H., Lin, Y. L., Mettling, C., Konate, K., Chazal, N., Arold, S. T., Pugnière, M., Sanchez, F., Bonhoure, A., Briant, L., Loret, E., Roy, C., and Beaumelle, B. (2010) Phosphatidylinositol-(4, 5)- bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J. 29, 1348-1362.
57. Touat, M., Ileana, E., Postel-Vinay, S., André, F., and Soria, J. C. (2015) Targeting FGFR signaling in cancer. Clin. Cancer Res. 21, 2684-2694.
58. Pardo, O. E., Wellbrock, C., Khanzada, U. K., Aubert, M., Arozarena, I., Davidson, S., Bowen, F., Parker, P. J., Filonenko, V. V., Gout, I. T., Sebire, N., Marais, R., Downward, J., and Seckl, M. J. (2006) FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B-Raf and S6K2. EMBO J. 25, 3078-3088.